Sequel Med Tech announced at the American Diabetes Association’s 85th Scientific Sessions in Chicago that it plans to launch its twiist system in July. Dr. Joanna Mitri, the company’s chief medical officer, shared the update in a Product Theater session at ADA today. Mitri said the company plans to launch the automated insulin delivery system […]
Diabetes
Dexcom shares U.S. report on CGM benefits for type 2 diabetes
Dexcom (Nasdaq:DXCM) has shared a new report highlighting access and attitudes toward type 2 diabetes in the U.S. The company released its report — “Dexcom State of Type 2 Report: Access and Attitudes Across the United States” — ahead of the American Diabetes Association’s 85th Scientific Sessions in Chicago. Findings provide insights into perceptions around […]
Study backs Tandem automated insulin delivery in pregnant women with type 1 diabetes
A new study showed improved glucose control in pregnant women using Tandem Diabetes Care (Nasdaq:TNDM) insulin delivery technology. The study showed that pregnant women with type 1 diabetes stayed in the target glucose range for pregnancy more with the Tandem t:slim X2 automated insulin delivery system with Control-IQ technology compared to standard insulin delivery with injections […]
Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
Medtronic (NYSE:MDT) today shared data supporting the use of its MiniMed 780G automated insulin delivery system in a range of patients. The medtech giant highlighted improved glycemic outcomes for those with type 2 diabetes and in young children. Investigators shared data at the American Diabetes Association’s 85th Scientific Sessions in Chicago. In one study, participants […]
Abbott could pave new roads in diabetes management with dual sensor on the horizon
About three years ago, Abbott (NYSE:ABT) announced that it had a new diabetes-related biowearable under development. The technology — a dual sensor that continuously monitors glucose and ketone levels — already had FDA breakthrough device designation. Abbott said at the time that it was set for pivotal trial use in 2023, with regulatory submissions to […]
Tandem Diabetes Care pairs t:slim X2 pump with Abbott FreeStyle Libre 3 Plus in U.S.
Tandem Diabetes Care (Nasdaq:TNDM) announced today that its t:slim X2 system now works with the Abbott (NYSE:ABT) FreeStyle Libre 3 Plus. This marks the latest pairing of automated insulin delivery (AID) and continuous glucose monitor (CGM) technologies between the companies. They announced the integration of FreeStyle Libre 2 Plus CGM into the t:slim X2 insulin pump in […]
Ypsomed, CamDiab to integrate Abbott dual glucose-ketone sensor into automated insulin delivery system
Ypsomed and CamDiab announced today that they agreed to integrate their mylife Loop automated insulin delivery system with a future Abbott (NYSE:ABT) sensor. The companies plan to pair their pump system with the Abbott dual glucose-ketone sensor, currently under development. Ypsomed and CamDiab join three other companies set to pair their pumps with the sensor after Abbott recently […]
PharmaSens, SiBionics collab on all-in-one insulin patch pump
PharmaSens today announced a strategic partnership with SiBionics to jointly develop an all-in-one insulin patch pump. Switzerland-based PharmaSens develops the Niia Essential insulin patch pump system. The basal-bolus patch pump combines the ease of an insulin pen with the advantages of a sophisticated pump. The company submitted the pump to the FDA at the end […]
Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor
Beta Bionics (Nasdaq:BBNX) announced today that it agreed to integrate its iLet bionic pancreas with a future dual sensor from Abbott (NYSE:ABT). The agreement pairs the iLet automated insulin delivery system with the sensor designed to continuously monitor glucose and ketone levels. This marks the third such integration for the Abbott dual sensor. The company […]
CeQur hits insulin patch milestone, highlights commercial expansion
CeQur announced today that it reached the milestone of 10 million mealtime insulin injections replaced with its Simplicity insulin patch. Horw, Switzerland began a pilot commercial launch for the FDA-cleared and CE-marked device in early 2021. In April 2021, the company raised $115 million to support that launch and scale up manufacturing. Since then, it says […]
